TriReme Medical
2005
FOUNDED
M&A
STATUS
101-200
EMPLOYEES
Merger of Eq.
LATEST DEAL TYPE
Description
Developer, manufacturer and distributor of advanced therapeutic technology systems designed for the treatment of complex vascular disease. The company develops next generation percutaneous devices for the treatment of coronary and peripheral vascular disease. Its novel balloon and stent therapies are specifically designed for the large, unmet clinical needs in the complex coronary and peripheral artery disease markets, providing physicians with new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.
Primary Office
- 7060 Koll Center Parkway
- Suite 300
- Pleasanton, CA 94566
- United States
+1 (925) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore TriReme Medical’s full profile, request a free trial.
TriReme Medical Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger of Equals | 11-Jul-2013 | 000.00 | Completed | Generating Revenue | ||
| 6. Later Stage VC | 28-Nov-2012 | 0000 | 000.00 | Completed | Generating Revenue | |
| 5. Later Stage VC (Series D) | 12-Oct-2010 | 0000 | 000.00 | 000.00 | Completed | Startup |
| 4. Early Stage VC | 10-Nov-2009 | 00.000 | 000.00 | Completed | Startup | |
| 3. Early Stage VC | 16-Oct-2007 | 000.00 | 000.00 | 000.00 | Completed | Startup |
| 2. Early Stage VC (Series B) | 27-Apr-2006 | $3.44M | $5.36M | 000.00 | Completed | Startup |
| 1. Early Stage VC (Series A) | 11-Nov-2005 | $1.92M | $1.92M | 000.00 | Completed | Startup |
TriReme Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series C | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series B | 2,264,157 | $0.001000 | $0.12 | $1.52 | $1.52 | 1x | $1.52 | 3.2% |
| Series A | 2,271,276 | $0.001000 | $0.08 | $1 | $1 | 1x | $1 | 3.21% |
TriReme Medical Competitors (13)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Tryton Medical | Venture Capital-Backed | Durham, NC | 00 | 000.00 | 00000000000 | 000.00 |
| 000000 00000000 | Venture Capital-Backed | Wayne, PA | 00 | 00000 | 00000000000 | 00000 |
| 0000000000000 | Corporation | New York, NY | 000 | 000000 - 000 | ||
| 0000000000 0000000 | Venture Capital-Backed | Fort Washington, PA | 00 | 000.00 | 00000000000 | 000.00 |
| 00000000 000000000 | Formerly VC-backed | Minneapolis, MN | 000 | 0000 | 000000&0 | 0000 |
TriReme Medical Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Adams Street Partners | Fund of Funds | Minority | 000 0000 | 000000 0 | ||
| Bio*One Capital | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Luminor Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Three Arch Partners | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Yellowstone Capital Partners | PE/Buyout | Minority | 000 0000 | 000000 0 |
TriReme Medical Executive Team (9)
3 Former Executives
You’re viewing 5 of 9 executives. Get the full list »